School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, The University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, Newcastle, NSW, Australia.
School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, The University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, Newcastle, NSW, Australia.
Biochim Biophys Acta Rev Cancer. 2023 May;1878(3):188882. doi: 10.1016/j.bbcan.2023.188882. Epub 2023 Mar 26.
The tumour suppressor p53 is activated following genotoxic stress and regulates the expression of target genes involved in the DNA damage response (DDR). The discovery that p53 isoforms alter the transcription of p53 target genes or p53 protein interactions unveiled an alternative DDR. This review will focus on the role p53 isoforms play in response to DNA damage. The expression of the C-terminally truncated p53 isoforms may be modulated via DNA damage-induced alternative splicing, whereas alternative translation plays an important role in modulating the expression of N-terminally truncated isoforms. The DDR induced by p53 isoforms may enhance the canonical p53 DDR or block cell death mechanisms in a DNA damage- and cell-specific manner, which could contribute to chemoresistance in a cancer context. Thus, a better understanding of the involvement of p53 isoforms in the cell fate decisions could uncover potential therapeutic targets in cancer and other diseases.
抑癌基因 p53 在受到遗传毒性应激后被激活,并调节参与 DNA 损伤反应 (DDR) 的靶基因的表达。p53 异构体改变 p53 靶基因的转录或 p53 蛋白相互作用的发现揭示了一种替代性的 DDR。本综述将重点讨论 p53 异构体在应对 DNA 损伤中的作用。C 端截断的 p53 异构体的表达可能通过 DNA 损伤诱导的选择性剪接来调节,而选择性翻译在调节 N 端截断异构体的表达中起着重要作用。p53 异构体诱导的 DDR 可能以 DNA 损伤和细胞特异性的方式增强经典的 p53 DDR 或阻断细胞死亡机制,这可能有助于癌症中的化疗耐药性。因此,更好地了解 p53 异构体在细胞命运决定中的作用可能会揭示癌症和其他疾病中的潜在治疗靶点。